KR101730288B1 - 펄스화된 dc 블록을 갖는 테스트 시퀀스로 분석물질을 전기화학적으로 측정하는 방법들, 및 그것을 통합한 디바이스들, 장치들 및 시스템들 - Google Patents
펄스화된 dc 블록을 갖는 테스트 시퀀스로 분석물질을 전기화학적으로 측정하는 방법들, 및 그것을 통합한 디바이스들, 장치들 및 시스템들 Download PDFInfo
- Publication number
- KR101730288B1 KR101730288B1 KR1020157029892A KR20157029892A KR101730288B1 KR 101730288 B1 KR101730288 B1 KR 101730288B1 KR 1020157029892 A KR1020157029892 A KR 1020157029892A KR 20157029892 A KR20157029892 A KR 20157029892A KR 101730288 B1 KR101730288 B1 KR 101730288B1
- Authority
- KR
- South Korea
- Prior art keywords
- block
- msec
- potential
- sec
- pulse
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000012360 testing method Methods 0.000 title claims abstract description 126
- 238000000034 method Methods 0.000 title claims abstract description 113
- 239000012491 analyte Substances 0.000 title claims abstract description 72
- 239000012530 fluid Substances 0.000 claims abstract description 49
- 238000005534 hematocrit Methods 0.000 claims abstract description 6
- 230000004044 response Effects 0.000 claims description 173
- 230000005284 excitation Effects 0.000 claims description 93
- 238000005259 measurement Methods 0.000 claims description 54
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 43
- 239000008103 glucose Substances 0.000 claims description 43
- 239000003153 chemical reaction reagent Substances 0.000 claims description 41
- 210000004369 blood Anatomy 0.000 claims description 14
- 239000008280 blood Substances 0.000 claims description 14
- 230000000694 effects Effects 0.000 claims description 13
- 238000004891 communication Methods 0.000 claims description 7
- 230000003750 conditioning effect Effects 0.000 claims description 5
- 238000012544 monitoring process Methods 0.000 claims description 2
- 238000000691 measurement method Methods 0.000 abstract description 17
- 239000000523 sample Substances 0.000 description 82
- 238000001208 nuclear magnetic resonance pulse sequence Methods 0.000 description 16
- 230000008901 benefit Effects 0.000 description 13
- 238000001514 detection method Methods 0.000 description 13
- 238000002848 electrochemical method Methods 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 9
- 238000009792 diffusion process Methods 0.000 description 8
- 238000003487 electrochemical reaction Methods 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- 230000008859 change Effects 0.000 description 7
- 238000000840 electrochemical analysis Methods 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 230000002829 reductive effect Effects 0.000 description 7
- 230000035945 sensitivity Effects 0.000 description 7
- 239000003814 drug Substances 0.000 description 6
- 238000005070 sampling Methods 0.000 description 6
- 238000012986 modification Methods 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 230000007704 transition Effects 0.000 description 5
- 238000013459 approach Methods 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 238000006479 redox reaction Methods 0.000 description 4
- 238000009736 wetting Methods 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 230000007613 environmental effect Effects 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- -1 markers Chemical class 0.000 description 3
- 102000039446 nucleic acids Human genes 0.000 description 3
- 108020004707 nucleic acids Proteins 0.000 description 3
- 150000007523 nucleic acids Chemical class 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000001427 coherent effect Effects 0.000 description 2
- 238000012937 correction Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 230000036278 prepulse Effects 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 239000012429 reaction media Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 230000009897 systematic effect Effects 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 108700012359 toxins Proteins 0.000 description 2
- 230000001052 transient effect Effects 0.000 description 2
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 1
- 238000012935 Averaging Methods 0.000 description 1
- 241000252095 Congridae Species 0.000 description 1
- 238000000018 DNA microarray Methods 0.000 description 1
- YEJCDKJIEMIWRQ-UHFFFAOYSA-N Linopirdine Chemical compound O=C1N(C=2C=CC=CC=2)C2=CC=CC=C2C1(CC=1C=CN=CC=1)CC1=CC=NC=C1 YEJCDKJIEMIWRQ-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 125000002015 acyclic group Chemical group 0.000 description 1
- 238000004082 amperometric method Methods 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000003869 coulometry Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 238000013016 damping Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 238000004870 electrical engineering Methods 0.000 description 1
- 238000007812 electrochemical assay Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 230000015654 memory Effects 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 238000002493 microarray Methods 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 230000010287 polarization Effects 0.000 description 1
- 238000004313 potentiometry Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000004832 voltammetry Methods 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/28—Electrolytic cell components
- G01N27/30—Electrodes, e.g. test electrodes; Half-cells
- G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
- G01N27/3271—Amperometric enzyme electrodes for analytes in body fluids, e.g. glucose in blood
- G01N27/3274—Corrective measures, e.g. error detection, compensation for temperature or hematocrit, calibration
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/28—Electrolytic cell components
- G01N27/30—Electrodes, e.g. test electrodes; Half-cells
- G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
- G01N27/3271—Amperometric enzyme electrodes for analytes in body fluids, e.g. glucose in blood
- G01N27/3273—Devices therefor, e.g. test element readers, circuitry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Electrochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Ecology (AREA)
- Biophysics (AREA)
- Diabetes (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361792748P | 2013-03-15 | 2013-03-15 | |
| US201361801826P | 2013-03-15 | 2013-03-15 | |
| US61/792,748 | 2013-03-15 | ||
| US61/801,826 | 2013-03-15 | ||
| PCT/EP2014/054965 WO2014140178A1 (en) | 2013-03-15 | 2014-03-13 | Methods of electrochemically measuring an analyte with a test sequence having a pulsed dc block as well as devices, apparatuses and systems incorporating the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20150131363A KR20150131363A (ko) | 2015-11-24 |
| KR101730288B1 true KR101730288B1 (ko) | 2017-04-25 |
Family
ID=50280376
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020157029892A Active KR101730288B1 (ko) | 2013-03-15 | 2014-03-13 | 펄스화된 dc 블록을 갖는 테스트 시퀀스로 분석물질을 전기화학적으로 측정하는 방법들, 및 그것을 통합한 디바이스들, 장치들 및 시스템들 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US10119931B2 (enExample) |
| EP (1) | EP2972270B1 (enExample) |
| JP (1) | JP6356708B2 (enExample) |
| KR (1) | KR101730288B1 (enExample) |
| CN (1) | CN105247358B (enExample) |
| CA (1) | CA2900885C (enExample) |
| WO (1) | WO2014140178A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL3523639T3 (pl) | 2016-10-05 | 2025-03-17 | F. Hoffmann-La Roche Ag | Odczynniki wykrywające i układy elektrod do elementów diagnostycznych testów wieloanalitowych oraz sposoby ich zastosowania |
| US11408881B2 (en) * | 2017-05-04 | 2022-08-09 | Roche Diabetes Care, Inc. | Test meter and method for detecting undue pressure applied to an inserated test strip |
| CN109406598A (zh) | 2017-08-17 | 2019-03-01 | 爱科来株式会社 | 测定方法以及测定装置 |
| CN109406591A (zh) | 2017-08-17 | 2019-03-01 | 爱科来株式会社 | 测定方法和测定装置 |
| JP2019074442A (ja) * | 2017-10-18 | 2019-05-16 | ルネサスエレクトロニクス株式会社 | インピーダンス測定用半導体回路及び血糖値計 |
| US11541385B2 (en) * | 2018-07-06 | 2023-01-03 | Qorvo Us, Inc. | Methods of measuring hematocrit in fluidic channels including conductivity sensor |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1156324A1 (en) | 1999-11-29 | 2001-11-21 | Matsushita Electric Industrial Co., Ltd. | Sample discriminating method |
| WO2003060154A2 (en) | 2002-01-15 | 2003-07-24 | Agamatrix, Inc. | Method and apparatus for processing electrochemical signals |
| US20040157339A1 (en) | 1997-12-22 | 2004-08-12 | Burke David W. | System and method for analyte measurement using AC excitation |
| US20090030641A1 (en) | 2007-10-23 | 2009-01-29 | Edwards Lifesciences Corporation | Monitoring and compensating for temperature-related error in an electrochemical sensor |
| EP2261646A1 (en) | 2008-03-27 | 2010-12-15 | Panasonic Corporation | Measurement device, measurement system, and concentration measurement method |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1042667B1 (en) | 1997-12-22 | 2009-06-17 | Roche Diagnostics Operations, Inc. | Meter |
| CA2311487C (en) * | 1998-05-13 | 2004-02-10 | Cygnus, Inc. | Signal processing for measurement of physiological analytes |
| WO2001021827A1 (en) * | 1999-09-20 | 2001-03-29 | Roche Diagnostics Corporation | Small volume biosensor for continuous analyte monitoring |
| US6541216B1 (en) * | 1999-12-22 | 2003-04-01 | Roche Diagnostics Corporation | Amperometric biosensor test strip |
| US6788965B2 (en) | 2001-08-03 | 2004-09-07 | Sensys Medical, Inc. | Intelligent system for detecting errors and determining failure modes in noninvasive measurement of blood and tissue analytes |
| US6856125B2 (en) * | 2001-12-12 | 2005-02-15 | Lifescan, Inc. | Biosensor apparatus and method with sample type and volume detection |
| EP1467206A1 (en) * | 2003-04-08 | 2004-10-13 | Roche Diagnostics GmbH | Biosensor system |
| US20070264721A1 (en) * | 2003-10-17 | 2007-11-15 | Buck Harvey B | System and method for analyte measurement using a nonlinear sample response |
| WO2005073708A2 (de) * | 2004-01-29 | 2005-08-11 | Siemens Aktiengesellschaft | Verfahren zur messung der konzentration oder konzentrationsänderung einer redoxaktiven substanz und zugehörige vorrichtung |
| US7569126B2 (en) | 2004-06-18 | 2009-08-04 | Roche Diagnostics Operations, Inc. | System and method for quality assurance of a biosensor test strip |
| US7964089B2 (en) | 2005-04-15 | 2011-06-21 | Agamatrix, Inc. | Analyte determination method and analyte meter |
| US7429865B2 (en) | 2005-10-05 | 2008-09-30 | Roche Diagnostics Operations, Inc. | Method and system for error checking an electrochemical sensor |
| EP1813937A1 (de) * | 2006-01-25 | 2007-08-01 | Roche Diagnostics GmbH | Elektrochemisches Biosensor-Analysesystem |
| CN101007789B (zh) | 2006-01-27 | 2014-08-20 | 北京摩力克科技有限公司 | 取代五元氮杂环盐类化合物及其治疗蛋白老化相关疾病的用途 |
| ES2791724T3 (es) | 2006-02-27 | 2020-11-05 | Ascensia Diabetes Care Holdings Ag | Medida de analito ajustada en temperatura para sistemas de biosensor |
| ES2748685T3 (es) * | 2006-09-22 | 2020-03-17 | Ascensia Diabetes Care Holdings Ag | Sistema de biosensor que tiene estabilidad y rendimiento de hematocrito potenciados |
| ES2397663T3 (es) * | 2006-10-05 | 2013-03-08 | Lifescan Scotland Limited | Sistemas y procedimientos para determinar una concentración de un analito sustancialmente independiente del hematocrito |
| CN101522095B (zh) * | 2006-10-24 | 2014-04-16 | 拜尔健康护理有限责任公司 | 瞬时衰变电流分析法 |
| US8778168B2 (en) | 2007-09-28 | 2014-07-15 | Lifescan, Inc. | Systems and methods of discriminating control solution from a physiological sample |
| CA2707300C (en) * | 2007-12-10 | 2017-09-26 | Bayer Healthcare Llc | Rapid-read gated amperometry |
| US8551320B2 (en) | 2008-06-09 | 2013-10-08 | Lifescan, Inc. | System and method for measuring an analyte in a sample |
| EP2656058A1 (en) * | 2010-12-22 | 2013-10-30 | Roche Diagnostics GmbH | Systems and methods to compensate for sources of error during electrochemical testing |
| WO2012134890A1 (en) | 2011-03-25 | 2012-10-04 | Cilag Gmbh International | System and method for measuring an analyte in a sample and correcting for interferents |
| US9201038B2 (en) * | 2012-07-24 | 2015-12-01 | Lifescan Scotland Limited | System and methods to account for interferents in a glucose biosensor |
| US9080196B2 (en) * | 2012-09-28 | 2015-07-14 | Cilag Gmbh International | System and method for determining hematocrit insensitive glucose concentration |
-
2014
- 2014-03-13 JP JP2015562152A patent/JP6356708B2/ja active Active
- 2014-03-13 EP EP14710246.1A patent/EP2972270B1/en active Active
- 2014-03-13 CA CA2900885A patent/CA2900885C/en active Active
- 2014-03-13 WO PCT/EP2014/054965 patent/WO2014140178A1/en not_active Ceased
- 2014-03-13 KR KR1020157029892A patent/KR101730288B1/ko active Active
- 2014-03-13 CN CN201480015532.0A patent/CN105247358B/zh active Active
-
2015
- 2015-09-11 US US14/851,621 patent/US10119931B2/en active Active
-
2018
- 2018-11-06 US US16/181,708 patent/US10809221B2/en active Active
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040157339A1 (en) | 1997-12-22 | 2004-08-12 | Burke David W. | System and method for analyte measurement using AC excitation |
| EP1156324A1 (en) | 1999-11-29 | 2001-11-21 | Matsushita Electric Industrial Co., Ltd. | Sample discriminating method |
| WO2003060154A2 (en) | 2002-01-15 | 2003-07-24 | Agamatrix, Inc. | Method and apparatus for processing electrochemical signals |
| US20090030641A1 (en) | 2007-10-23 | 2009-01-29 | Edwards Lifesciences Corporation | Monitoring and compensating for temperature-related error in an electrochemical sensor |
| EP2261646A1 (en) | 2008-03-27 | 2010-12-15 | Panasonic Corporation | Measurement device, measurement system, and concentration measurement method |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2014140178A1 (en) | 2014-09-18 |
| JP2016510124A (ja) | 2016-04-04 |
| EP2972270A1 (en) | 2016-01-20 |
| KR20150131363A (ko) | 2015-11-24 |
| US20160003764A1 (en) | 2016-01-07 |
| US10119931B2 (en) | 2018-11-06 |
| CN105247358A (zh) | 2016-01-13 |
| JP6356708B2 (ja) | 2018-07-11 |
| US20190204258A1 (en) | 2019-07-04 |
| US10809221B2 (en) | 2020-10-20 |
| CA2900885A1 (en) | 2014-09-18 |
| HK1219778A1 (zh) | 2017-04-13 |
| EP2972270B1 (en) | 2018-04-25 |
| CA2900885C (en) | 2017-12-19 |
| CN105247358B (zh) | 2017-11-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10809221B2 (en) | Methods of electrochemically measuring an analyte with a test sequence having a pulsed DC block as well as devices, apparatuses and systems incorporating the same | |
| KR101771829B1 (ko) | 분석물질을 전기화학적으로 측정하는 디스크립터-기반 방법들 및 그것을 통합한 디바이스들, 장치들 및 시스템들 | |
| JP6356705B2 (ja) | バイオセンサ・アルゴリズムを構築に用いるスケーリング・データの方法ならびにデバイス、装置およびシステム | |
| JP6352954B2 (ja) | 電気化学的な分析物測定において回復パルスからの情報を使用する方法およびデバイス、装置とそれらを組み込むシステム | |
| KR20160023891A (ko) | 분석물을 함유한 샘플의 감지된 물리적 특성으로부터 도출된 지정 샘플링 시간으로부터 결정되는 분석물 측정을 위한 충전 에러 트랩 | |
| WO2014072948A1 (en) | System and method for detection of sample volume during initial sample fill of a biosensor to determine glucose concentration in fluid samples or sample fill error | |
| RU2793144C1 (ru) | Способ для определения концентрации аналита в пробе | |
| CA3148529C (en) | Method for determining analyte concentration in a sample | |
| HK1219778B (en) | Methods of electrochemically measuring an analyte with a test sequence having a pulsed dc block as well as devices, apparatuses and systems incorporating the same | |
| HK1214354B (en) | Descriptor-based methods of electrochemically measuring an analyte as well as devices, apparatuses and systems incorporating the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| PA0105 | International application |
Patent event date: 20151015 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PA0201 | Request for examination | ||
| PG1501 | Laying open of application | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20160831 Patent event code: PE09021S01D |
|
| E701 | Decision to grant or registration of patent right | ||
| PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20170329 |
|
| GRNT | Written decision to grant | ||
| PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20170419 Patent event code: PR07011E01D |
|
| PR1002 | Payment of registration fee |
Payment date: 20170419 End annual number: 3 Start annual number: 1 |
|
| PG1601 | Publication of registration | ||
| PR1001 | Payment of annual fee |
Payment date: 20200324 Start annual number: 4 End annual number: 4 |
|
| PR1001 | Payment of annual fee |
Payment date: 20210329 Start annual number: 5 End annual number: 5 |
|
| PR1001 | Payment of annual fee |
Payment date: 20220325 Start annual number: 6 End annual number: 6 |
|
| PR1001 | Payment of annual fee |
Payment date: 20230327 Start annual number: 7 End annual number: 7 |
|
| PR1001 | Payment of annual fee |
Payment date: 20240401 Start annual number: 8 End annual number: 8 |
|
| PR1001 | Payment of annual fee |
Payment date: 20250324 Start annual number: 9 End annual number: 9 |